1. Home
  2. ARTW vs NEUP Comparison

ARTW vs NEUP Comparison

Compare ARTW & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Art's-Way Manufacturing Co. Inc.

ARTW

Art's-Way Manufacturing Co. Inc.

N/A

Current Price

$2.39

Market Cap

11.9M

Sector

Industrials

ML Signal

N/A

NEUP

Neuphoria Therapeutics Inc.

N/A

Current Price

$3.84

Market Cap

10.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ARTW
NEUP
Founded
1956
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.9M
10.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ARTW
NEUP
Price
$2.39
$3.84
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$21.00
AVG Volume (30 Days)
26.3K
83.5K
Earning Date
02-10-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.49
N/A
Revenue
$24,079,949.00
$15,649,448.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.43
$2.90
52 Week High
$4.71
$21.40

Technical Indicators

Market Signals
Indicator
ARTW
NEUP
Relative Strength Index (RSI) 54.51 38.35
Support Level $2.29 $3.65
Resistance Level $2.48 $3.91
Average True Range (ATR) 0.12 0.19
MACD 0.02 0.09
Stochastic Oscillator 64.71 29.52

Price Performance

Historical Comparison
ARTW
NEUP

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share on Social Networks: